What are the risks of investing in AMGN?
A
What are the risks of investing in AMGN?
🦉
Amgen Inc. (AMGN)
Company Overview
Sector / IndustryHealthcare / Drug Manufacturers - General
CEORobert A. Bradway
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis,...
Key Executives
| Name | Title |
|---|---|
| Casey Capparelli | Executive Director of Investor Relations |
| David Reese | Executive Vice President & Chief Technology Officer |
| Esteban Santos | Executive Vice President of Operations |
| Howard Y. Chang | Senior Vice President of Global Research & Chief Scientific Officer |
| James E. Bradner | Executive Vice President of Research & Development |
| Matthew C. Busch | Chief Accounting Officer & Vice President of Finance |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A